from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2492/-

LFCtreatmentdescriptionclass of inhibitor

0.287

Amikacinug/mL Amikacintranslation

-0.566

Cap5-10ug/mL Capreomycintranslation

0.829

Rox10-50 ug/mL Roxithromycintranslation

0.541

SM2-5 ug/mL Streptomycintranslation

1.143

Tet5-10 ug/mL Tetracyclinetranslation

0.278

Rif0.2-5ug/mL Rifampicintranscription

0.709

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.620

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.146

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.113

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.541

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.520

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.147

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.366

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.723

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.489

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.317

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.071

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.547

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.193

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.163

Nigericin50 uM Nigericinrespiration

-0.517

TRC10-150 ug/mL Triclosanrespiration

-0.689

TRZ10-25 ug/mL Thioridazinerespiration

-0.198

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.703

menadione6-10 ug/mL Menadionerespiration

-0.841

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.008

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.237

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.124

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.416

NRP_1Non-replicating persistence stage 1dosRassociated

-0.174

Amp0.2mg/mL AmpicillincellWall

0.147

Cephalexin20-100 ug/mL CephalexincellWall

0.935

Cerulenin0.32-5 ug/mL CerulenincellWall

0.505

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.191

EMB10-20 ug/mL EthambutolcellWall

-0.936

Eta12-40 ug/mL EthionamidecellWall

-0.286

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.642

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.343

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.014

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.158

BZA0.12 mg/mL BenzamidearomaticAmides

0.399

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.125

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.228

H2O24 mM hydrogen peroxideDNAdamaging

-0.168

Levo10 ug/mL LevofloxacinDNAdamaging

-0.453

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.426

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.347

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.565

UVUV-irradiationDNAdamaging

0.336

ARP41-4 ug/mL Antitubercular compound ARP4?

0.163

Antimycin12.5-50 ug/mL Antimycin A?

-0.421

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.928

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.215

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.651

PA8240.2-2 ug/mL PA-824?

0.053

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.447

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.297

Verapamil50 uM Verapamil?

-0.259

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.267

methoxatin10-20 ug/mL Methoxatin?